๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins

โœ Scribed by Christoph Kempf; Martin Stucki; Nicola Boschetti

Book ID
113491572
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
197 KB
Volume
35
Category
Article
ISSN
1045-1056

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Quality control in the production of an
Quality control in the production of an immunoglobulin for intravenous use
โœ Gardi, A. ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer-Verlag โš– 406 KB

This paper briefly surveys the control measures and tests which are carried out before, during and after manufacture of an i.v. immunoglobulin in order to assure the quality of the preparation. The quality requirements are determined by both the standards expected by physicians and patients and by t

Virus safety of human immunoglobulins: E
Virus safety of human immunoglobulins: Efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure
โœ Thomas Nowak; Jens-Peter Gregersen; Ulrich Klockmann; Larry Bill Cummins; Dr. Jo ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 720 KB

## Abstract Human immunoglobulins are plasma derivatives with a low risk of transmitting viral infections. To the present, no proven case of human immunoglobulins transmitting human immunodeficiency viruses has been reported. However, there have been a few reports on the transmission of hepatitis C